LON:NIPT

Premaitha Health (NIPT) Share Price, News & Analysis

Premaitha Health logo

About Premaitha Health Stock (LON:NIPT)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.57 million shs
Average Volume
1.35 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NIPT Stock News Headlines

Elon masterplan could turn $500 into half a million
Jeff Brown called Tesla an AI company in 2018, when Wall Street said it was going bankrupt. The stock has been up as much as 2,433% since. Now Brown says Elon Musk is about to take the final step of his masterplan, and one company is critical to it. Musk has predicted a return of more than 1,000x for early investors. In a free video, Brown shows what Musk is building and names one of his key partners.tc pixel
See More Headlines

NIPT Stock Analysis - Frequently Asked Questions

Premaitha Health PLC (LON:NIPT) posted its earnings results on Friday, December, 29th. The company reported GBX (2) earnings per share for the quarter. The business earned £2.71 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Premaitha Health investors own include Aviva (AV), Nighthawk Energy (HAWK), Lloyds Banking Group (LLOY), Plethora Solutions (PLE), Rose Petroleum plc (ROSE.L) (ROSE), Sareum (SAR) and Tesco (TSCO).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Laboratories & Research
Sub-Industry
N/A
Current Symbol
LON:NIPT
Previous Symbol
LON:VIY
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (LON:NIPT) was last updated on 11/6/2018 by MarketBeat.com Staff.
From Our Partners